Platelet-Rich Plasma in Treatment of Zoledronic Acid-Induced Bisphosphonate-related osteonecrosis of the jaws
Open Access
- 18 March 2014
- journal article
- Published by Briefland in Trauma Monthly
- Vol. 19 (2)
- https://doi.org/10.5812/traumamon.17196
Abstract
Bisphosphonate-related osteonecrosis of the jaws (BRONJ) is a well-known challenging entity warranting management. Platelet-Rich Plasma (PRP) plays an important role in bone biology by enhancing bone repair and regeneration. The aim of this animal study was to evaluate the effects of PRP on zoledronic acid-induced BRONJ. Seven rats were given 0.04 mg Zoledronic acid intravenously once a week for five weeks. Two weeks later, the animals underwent extraction of their first lower molars, bilaterally. After clinical confirmation of the osteonecrosis, PRP was injected randomly into one of the extraction sockets of each rat. Three weeks later, all rats were sacrificed in order to obtain histological sections. The analysis of epithelialization was performed by McNamar’s test, and the analysis of osteogenesis and angiogenesis was performed by the Wilcoxon Sign Rank test. P value was set at 0.05. We found no significant differences between the two groups regarding the amount of epithelialization, angiogenesis or sequestrum formation (P > 0.05), but a significant difference was seen between the two groups regarding the amount of existing vital bone (P < 0.05). Our study demonstrates positive results (preservation or regeneration of bone) using PRP in treatment of BRONJ. Although PRP may enhance osseous regeneration, long-term follow-ups are required to confirm its benefits.Keywords
This publication has 47 references indexed in Scilit:
- Platelet-rich therapies in the treatment of intravenous bisphosphonate-related osteonecrosis of the jaw: A report of 32 casesOral Oncology, 2012
- Learning from experience. Proposal of a refined definition and staging system for bisphosphonate‐related osteonecrosis of the jaw (BRONJ)Oral Diseases, 2012
- Bisphosphonates‐related osteonecrosis of the jaws: a concise review of the literature and a report of a single‐centre experience with 151 patientsJournal of Oral Pathology & Medicine, 2011
- Antibiotic effects on bacterial profile in osteonecrosis of the jawOral Diseases, 2011
- Bisphosphonate-Related Osteonecrosis of the Jaws–An Initial Case Series Report of Treatment Combining Partial Bone Resection and Autologous Platelet-Rich PlasmaJournal of Oral and Maxillofacial Surgery, 2011
- Effects of alendronate on bone healing after tooth extraction in ratsOral Diseases, 2010
- Effect of alendronate on alveolar bone resorption and angiogenesis in rats with experimental periapical lesionsInternational Endodontic Journal, 2010
- Value of a New Fixed-Combination Pack of Bisphosphonate, Calcium and Vitamin D in the Therapy of OsteoporosisDrugs & Aging, 2009
- Bisphosphonates: Clinical ExperienceThe Oncologist, 2004
- Bisphosphonates and Tumor BurdenJournal of Clinical Oncology, 2002